Company profile for Cytokinetics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular dis...
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and best-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function, like heart failure, hypertrophic cardiomyopathies (HCM), amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
280 East Grand Ave South San Francisco, CA 94115
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/18/3190469/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html

GLOBENEWSWIRE
18 Nov 2025

https://www.fiercebiotech.com/biotech/were-built-it-why-cytokinetics-doesnt-want-big-pharma-support-supersede-camzyos

FIERCE PHARMA
18 Nov 2025

https://www.globenewswire.com/news-release/2025/11/17/3189141/35409/en/Cytokinetics-Supports-American-Heart-Association-Initiative-to-Improve-Care-for-People-Living-With-Hypertrophic-Cardiomyopathy.html

GLOBENEWSWIRE
17 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3184429/35409/en/Cytokinetics-Presents-Additional-Data-from-MAPLE-HCM-at-the-Hypertrophic-Cardiomyopathy-Medical-Society-Scientific-Sessions-and-American-Heart-Association-Scientific-Sessions-2025.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181891/35409/en/Cytokinetics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180799/35409/en/Cytokinetics-to-Participate-in-November-Investor-Conferences.html

GLOBENEWSWIRE
04 Nov 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty